MENU
MCRB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Seres Therapeutics (MCRB) Ownership - Who owns Seres Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
101 Cambridgepark Drive
Phone
+1 617 945-9626
Employees
233
Web
https://www.serestherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
157.39M
P/E Ratio
N/A
Total Cash
66.82M
Projected Growth
N/A
Total Debt
93.61M
Revenue
126.33M
Risk (Beta)
0.29
Dividend Yield
N/A
Total Cash/Share
0.39
Total Debt/Equity
N/A
Revenue/Share
0.87 USD as % of share price
Fundamentals
MCRB
Capitalization
157M
P/E Ratio
N/A
Risk (Beta)
0.29
Dividend Yield
N/A
Total Cash
66.8M
Total Cash/Share
0.39
Total Debt
93.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.87%
Revenue
126M
ROE
N/A
Book Value
23.9M
P/B Ratio
6.54
Cash Flow
N/A
Earnings
-0.21
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
170K
Current Ratio
1.12
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-51.72M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-9.32
Shares Held By Institutions
85.4M
Shares Outstanding - Current
171M
Total Liabilities
155M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-34.607
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel treatments for diseases related to the human microbiome
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
101 Cambridgepark Drive
Phone
+1 617 945-9626
Employees
233
Web
https://www.serestherapeutics.com